Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

The Clinic ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 7.5% 7.5%   Bankruptcy risk   11.9% 12.8% 10.6% 10.1% 30.6% 22.8% 14.5% 14.5%   Credit score (0-100)   21 19 23 23 1 2 2 2   Credit rating   B B B B C C B B   Credit limit (kDKK)   -0.0 0.0 -0.0 0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   328 634 424 462 -470 -85.3 0.0 0.0   EBITDA   44.6 107 -10.5 451 -499 -138 0.0 0.0   EBIT   27.0 89.2 -28.1 434 -509 -156 0.0 0.0   Pre-tax profit (PTP)   4.3 65.3 -55.1 405.9 -520.3 -167.9 0.0 0.0   Net earnings   3.3 50.6 -43.6 316.0 -407.3 -131.3 0.0 0.0   Pre-tax profit without non-rec. items   4.3 65.3 -55.1 406 -520 -168 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   422 404 387 4.0 65.1 47.3 0.0 0.0   Shareholders equity total   -198 -148 -191 125 -283 -414 -464 -464   Interest-bearing liabilities   0.0 0.0 0.0 0.0 8.5 3.1 464 464   Balance sheet total (assets)   696 773 699 366 271 291 0.0 0.0   Net Debt   -34.6 -148 -77.4 -314 -9.7 -50.7 464 464     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   328 634 424 462 -470 -85.3 0.0 0.0   Gross profit growth   227.6% 93.3% -33.1% 9.0% 0.0% 81.9% 0.0% 0.0%   Employees   1 1 1 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% -100.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   696 773 699 366 271 291 0 0   Balance sheet change%   4.2% 11.1% -9.6% -47.7% -25.9% 7.6% -100.0% 0.0%   Added value   44.6 106.9 -10.5 451.3 -491.8 -138.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -35 -35 -35 -400 51 -36 -47 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.2% 14.1% -6.6% 93.8% 108.3% 183.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.1% 9.8% -3.1% 69.0% -111.1% -24.8% 0.0% 0.0%   ROI %   0.0% 0.0% 0.0% 690.6% -761.6% -2,693.3% 0.0% 0.0%   ROE %   0.5% 6.9% -5.9% 76.7% -206.0% -46.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -22.2% -16.0% -21.5% 34.1% -51.1% -58.7% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -77.6% -139.0% 739.8% -69.6% 1.9% 36.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% -3.0% -0.7% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 232.6% 201.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.3 0.2 1.4 0.3 0.3 0.0 0.0   Current Ratio   0.3 0.4 0.3 1.5 0.4 0.3 0.0 0.0   Cash and cash equivalent   34.6 148.5 77.4 314.2 18.2 53.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -620.3 -552.0 -587.7 111.8 -357.4 -471.1 -232.0 -232.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   45 107 -10 0 0 -138 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   45 107 -10 0 0 -138 0 0   EBIT / employee   27 89 -28 0 0 -156 0 0   Net earnings / employee   3 51 -44 0 0 -131 0 0